Summary

The United Kingdom contraceptive devices market size is estimated to expand at a CAGR of around 8.01% over the forecast period. The rising awareness in the regional population regarding contraception methods, investments by key players to develop innovative devices, and favorable government initiatives to improve access to products are the major factors accelerating the growth of the market.

In addition, rising the prevalence of sexually transmitted diseases and the growing need for population control fueling the regional market growth. For instance, as per the data published by the Institute for Health Metrics and Evaluation, there was 8.50 million UK population were living with HIV/AIDS & sexually transmitted diseases in the year 2019. Thus the increasing diseases have increased the demand for contraceptive devices that is likely to aid market growth. Moreover, initiatives by governments to raise awareness regarding contraceptives and family planning have also helped the growth of the market.

Key Market Trends

Condoms are Expected to Dominate the United Kingdom Contraceptive Devices Market

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. They also to a lesser extent protect against genital herpes, human papillomavirus (HPV), and syphilis.

In the United Kingdom, the use of condoms has significantly increased in adolescents due to easy availability and convenience and the rising prevalence of Sexually transmitted disorders. According to the survey conducted by Public Health England (PHE), in 2017, chlamydia or gonorrhoea claimed a young person every 4 minutes in England. There were over 144,000 diagnoses of these sexually transmitted infections (STIs) in people aged 15 to 24 in 2017. Thus, effective protection from sexually transmitted infections and high demand from the young population to enhance their sexual experience is expected to aid the product demand.

Competitive Landscape

The market is moderately competitive in nature. Some of the key industry contributors are AbbVie Inc. (Allergan), Bayer Healthcare, Cooper Surgical Inc. and Mylan Laboratories among others. Companies are undertaking strategic initiatives such as increasing investment in R&D of innovative products to gain a competitive edge from generic products available in the market.

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support

ページTOPに戻る

Table of Contents